| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Ankyrin repeat and SAM domain-containing protein 4B (358-408 aa) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:1000-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
ANKS4B |
| Gene ID: |
257629 |
| Uniprot ID: |
ANS4B_HUMAN |
| Immunogen Region: |
358-408 aa |
| Specificity: |
This antibody detects endogenous levels of human ANS4B |
| Immunogen: |
Synthesized peptide derived from the human ANS4B at the amino acid range 358-408 |
| Function | As part of the intermicrovillar adhesion complex/IMAC plays a role in epithelial brush border differentiation, controlling microvilli organization and length. Plays a role in assembly of the complex. May play a role in cellular response to endoplasmic reticulum stress. |
| Protein Name | Ankyrin Repeat And Sam Domain-Containing Protein 4bHarmonin-Interacting Ankyrin Repeat-Containing ProteinHarp |
| Cellular Localisation | Cell ProjectionMicrovillusLocalizes At The Tip Of MicrovilliMay Associate With Endoplasmic Reticulum Membranes |
| Alternative Antibody Names | Anti-Ankyrin Repeat And Sam Domain-Containing Protein 4b antibodyAnti-Harmonin-Interacting Ankyrin Repeat-Containing Protein antibodyAnti-Harp antibodyAnti-ANKS4B antibodyAnti-HARP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
